The switch from fetal to adult erythropoiesis

Clinics in Perinatology

Volumn 27, Issue 3, 2000, Pages 507-526

  Dame, Christof ^a   Juul, Sandra E ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; CD34 ANTIGEN; CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLOBIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; HEMOGLOBIN; INTERLEUKIN 3; OXYGEN; PHOSPHOTRANSFERASE; PROTEIN; RECOMBINANT ERYTHROPOIETIN; RNA; STEM CELL FACTOR; THROMBOPOIETIN;

AORTA; BONE MARROW; ERYTHROCYTE; ERYTHROPOIESIS; GENE CONTROL; HEMATOCRIT; HEMATOPOIETIC STEM CELL; HUMAN; KIDNEY; LIVER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN; STEM CELL; YOLK SAC;

EID: 0033837464     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(05)70036-1     Document Type: Article

References (143)

1. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein
2. Embryogenesis and anatomic development of the kidney
3. The effect of placental insufficiency on fetal and adult hemoglobin synthesis
4. Hemoglobin synthesis and metabolism during the neonatal period
5. The postnatal decline of hemoglobin F synthesis in normal full-term infants
6. Enhancer element at the 3'-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene
7. The effect of maternal water deprivation on ovine fetal blood volume
8. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo
9. Hypoxic induction of the human erythropoietin gene: Cooperation between the promoter and enhancer, each of which contains steroid receptor response elements
10. Regulation of the erythropoietin gene
11. Erythropoietin receptor characteristics on primary human erythroid cells
12. Decreased response of plasma immunoreactive erythropoietin to 'available oxygen' in anemia of prematurity
13. Postnatal changes in erythropoietin levels in untransfused premature infants
14. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults
15. Assessment of the contribution of the spleen to granulocytopoiesis and erythropoiesis of the mid-gestation human fetus
16. Erythropoietin levels in amniotic fluid and extraembryonic coelomic fluid in the first trimester of pregnancy
17. Early ontogeny of the human marrow from long bones: An immunohistochemical study of hematopoiesis and its microenvironment
18. Hemangioblast development and regulation
19. A common precursor for hematopoietic and endothelial cells
20. Developmental regulation of beta-globin gene switching
21. Expected hematologic values for term and preterm neonates
22. Hydrops fetalis caused by alpha-thalassemia: An emerging health care problem
23. Relation of beta to gamma synthesis during the first trimester: An approach to prenatal diagnosis of thalassemia
24. The anemia of hypophsectomized animals
25. Hemoglobin switching and fetal hemoglobin reactivation
26. Erythropoietin mRNA expression in human fetal and neonatal tissue
27. Regulation der fetalen Erythropoiese beim M. haemolyticus
28. Erythropoietin in Rhesus hemolytic disease during pregnancy and in the first trimenon
29. Functional and molecular analysis of hematopoietic progenitors derived from the aorta-gonad-mesonephros region of the mouse embryo
30. Intraembryonic hematopoietic stem cells
31. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2
32. Erythropoietin responsive progenitors in anaemia of prematurity
33. Development of the human yolk sac
34. Electron microscopic studies of macrophages in early human yolk sacs
35. Renal and extrarenal erythropoietin production in anaemic rats
36. Erythropoietin concentrations and erythropoiesis in newborns suffering from renal agenesis and congenital kidney diseases
37. Biochemical monitoring of fetal distress with serum-immunoreactive erythropoietin
38. Potentiation of interferon action by mixtures of recombinant DNA-derived human interferons
39. The liver as a source of extrarenal erythropoietin production
40. The sheep erythropoietin gene: Molecular cloning and effect of hemorrhage on plasma erythropoietin and renal/liver messenger RNA in adult sheep
41. Human embryonic haemoglobins Gower 1 and Gower 2
42. Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors
43. The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1
44. Induction of hypoxia-inducible factor-l, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: Evidence against a regulatory role for Src kinase
45. Plasma erythropoietin levels following hypothalamic stimulation in the rabbit
46. Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro
47. Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta 1 integrins
48. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow
49. Characterization of hematopoietic progenitors from human yolk sacs and embryos
50. Integrins: Versatility, modulation, and signaling in cell adhesion
51. HGF activates signal transduction from EPO receptor on human cord blood CD34+/CD45 + cells
52. Role of hepatocyte growth factor in hemopoiesis
53. Positive and negative regulation of the erythropoietin gene
54. Fetal and maternal erythropoietin levels in normal pregnancy
55. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha
56. Role of the kidney in erythropoiesis
57. Erythropoietin: Structure, control of production, and function
58. Increased erythrocyte deformability in fetal erythropoiesis and in erythrocytes deficient in glucose-6-phosphate dehydrogenase and other glycolytic enzymes
59. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus
60. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain
61. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy
62. Hemoglobin A synthesis in the developing fetus
63. A common precursor for primitive erythropoiesis and definitive haematopoiesis
64. Serum erythropoietin levels during infancy: Associations with erythropoiesis
65. Erythropoietin production by the kidney
66. The molecular biology of erythropoietin
67. Developmental changes in the function of hematopoietic stem cells
68. Self-renewal of stem cells
69. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis
70. Serum erythropoietin in small for gestational age fetuses
71. Alpha thalassemia
72. Regulation of erythropoietin gene expression in fetal sheep by glucocorticoids
73. Embryonic hemoglobins are expressed in definitive cells
74. Developmental stage-specific expression of the erythropoietin gene and the a and b subunits of the HIF-1 protein
75. Normal blood cell values in the early mid-trimester fetus
76. Effects of the hypothalamic stimulation on the erythropoietic response in the Rhesus monkey
77. Developmental regulation of erythropoietin and erythropoiesis
78. Differentiation of hemangioblasts from embryonic mesothelial cells? A model on the origin of the vertebrate cardiovascular system
79. Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells
80. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis
81. Cordocentesis in the investigation of fetal erythropoiesis
82. In vivo telomere dynamics of human hematopoietic stem cells
83. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5
84. Development of the hematopoietic system
85. GATA-binding transcription factors in hematopoietic cells
86. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse
87. Developmental biology of erythropoiesis
88. Quantitative correlation between globin mRNAs and synthesis of fetal and adult hemoglobins during hemoglobin switchover in the perinatal period
89. Erythropoietin production by the liver in fetal-neonatal life
90. Erythropoietin production in the rat: Additive role of kidney and liver
91. The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions - Comparison to other cytokines and growth factors
92. The ontogeny of erythropoiesis in the mouse detected by the erythroid colony-forming technique: II. Transition in erythropoietin sensitivity during development
93. The hemangioblast - An elusive cell captured in culture
94. Hematopoietic commitment during embryogenesis
95. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: Implications for anatomical localization and developmental stage specific regulation of hematopoiesis
96. Prediction of perinatal brain damage by cord plasma vasopressin, erythropoietin, and hypoxanthine values
97. Postnatal changes in serum immunoreactive erythropoietin in relation to hypoxia before and after birth
98. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo
99. Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation
100. Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors
101. Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells
102. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene
103. Assignment of the hypoxia-inducible factor 1alpha gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q
104. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
105. Hematopoiesis in the liver and marrow of human fetuses at 5 to 16 weeks postconception: Quantitative assessment of macrophage and neutrophil populations
106. Fetal plasma erythropoietin concentration in severe growth retardation
107. Dose-response relationship of megakaryocyte progenitors from bone marrow and peripheral blood of thrombocytopenic neonates to recombinant thrombopoietin
108. Hemoglobin switching
109. Hematopoiesis and granulopoiesis
110. Anemia of prematurity
111. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia
112. Embryonic and fetal hemopoiesis: An overview
113. Aorta-associated CD34+ hematopoietic cells in the early human embryo
114. Fetal plasma erythropoietin concentration in red blood cell-isoimmunized pregnancies
115. Human foetal haematopoiesis: I. The cellular composition of foetal blood
116. Human foetal haematopoiesis: II. Hepatic haematopoiesis in the human foetus
117. Knock-in mutation of transcription factor GATA-3 into the GATA-1 locus: Partial rescue of GATA-1 loss of function in erythroid cells
118. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age
119. Purification and characterization of hypoxia-inducible factor 1
120. Developmentally regulated responsiveness to transforming growth factor-beta is correlated with functional differences between human adult and fetal primitive hematopoietic progenitor cells
121. CD34+ + CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source
122. Increased immunoreactive erythropoietin in cord serum after labor
123. Erythropoietin receptor gene expression in humans is greater in the fetus compared to the adult
124. Impermeability of the ovine placenta to 35S-recombinant erythropoietin
125. Erythropoietin levels and erythropoiesis at birth in infants with Potter syndrome
126. Lack of maternal to fetal transfer of 125I-labelled erythropoietin in sheep
127. Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses
128. Developmental differences in erythropoietin pharmacokinetics: Increased clearance and distribution in fetal and neonatal sheep
129. Erythropoietin pharmacokinetics in premature infants: Developmental, nonlinearity, and treatment effects
130. Evidence to suggest that the human fetal spleen is not a hematopoietic organ
131. The complexities of beta globin gene regulation
132. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor
133. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants
134. Embryonic hematopoiesis
135. Matrix molecule interactions with hematopoietic stem cells
136. Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells
137. Liver to kidney switch of erythropoietin formation
138. Studies on the liver to kidney switch of erythropoietin production
139. Liver as the primary site of erythropoietin formation in the fetus
140. The erythrocyte differential count in newborn infants
141. Developmental biology of hematopoiesis